Hemlibra (emicizumab), the only treatment currently available for haemophilia A via the NHS that doesn't require an ...

The recent move to introduce an “Amazon-style” prescription tracking in the NHS App is a crucial first step. People want ...

"For decades, bureaucrats and entrenched interests buried health data and blocked patients from taking control of their ...

From trade associations to medtech innovators and biotech start-ups, here’s a comprehensive look at the latest boardroom ...

In a new study, the large-language model (LLM) ChatGPT was able to reduce the time needed to review whether a patient is suitable for a clinical trial and delivered big reductions – from an average of ...

President Donald Trump has given leading pharma manufacturers a 60-day deadline to come up with a most favoured nation (MFN) ...

The foundational model could also assist Google and partner Samsung in an ongoing rivalry with Apple, currently the leader in ...

The target is to reduce its workforce to less than 5,000 from a level of 5,800 at the end of 2024, said chief executive ...

When Tidmarsh was appointed to CDER, the FDA emphasised his academic and clinical credentials – including his role as ...

Vinay Prasad has stepped down as head of the FDA's Center for Biologics Evaluation and Research (CBER), less than three ...

The results of the SURPASS-CVOT trial showed that dual GLP-1/GIP agonist Mounjaro (tirzepatide) was as effective as Lilly's ...

There was consternation among the research community yesterday after it emerged that the White House's Office of Management ...